ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. AcouSort AB's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -86.74%.
As of today (2026-06-26), AcouSort AB's WACC % is 3.07%. AcouSort AB's ROC % is -94.13% (calculated using TTM income statement data).
AcouSort AB earns returns that do not match up to its cost of capital. It will destroy value as it grows.
AcouSort AB (STU:4SA) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, AcouSort AB's WACC % is 3.07%. AcouSort AB's ROC % is -94.13% (calculated using TTM income statement data).
AcouSort AB earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
AcouSort AB ROC % Related Terms
AcouSort AB ROC % Historical Data
* Premium members only.
The historical data trend for AcouSort AB's ROC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AcouSort AB (STU:4SA) has a ROC % of -86.74% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on AcouSort AB and its competitors.
Is AcouSort AB's ROC % too high?
AcouSort AB's current ROC % is -86.74%. Overall, AcouSort AB has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does AcouSort AB's ROC % compare to VRTX and REGN?
AcouSort AB's ROC % of -86.74% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on AcouSort AB and its competitors. AcouSort AB's current ROC % is -86.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcouSort AB stock overvalued right now?
AcouSort AB (STU:4SA) has a current ROC % of -86.74%. The stock's GF Value™ is €0.67, compared to a current price of €0.26 — trading 60.7% below its estimated fair value. The current ROC % is -86.74%. AcouSort AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For AcouSort AB (STU:4SA), the current ROC % is -86.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AcouSort AB (STU:4SA) Overvalued in 2026?
Based on GuruFocus' analysis, AcouSort AB stock appears to be undervalued.
The current stock price of €0.26 is trading 60.7% below its estimated GF Value™ of €0.67.
Key valuation signals for STU:4SA:
ROC %: -86.74%
GF Value™: €0.67 vs. price of €0.26 (60.7% below fair value)
No single metric tells the full story. See the STU:4SA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products includes AcouTrap, AcouWash, and AcouPlasma.
50GF Score
Get the complete analysis for STU:4SA
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:4SA has been successfully added to your 
